Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NOVAVAX INC Director's Dealing 2017

Dec 19, 2017

31982_dirs_2017-12-19_ec04e9c4-9365-4c8e-84d3-6c55b068a7f0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2017-12-15

Reporting Person: DOUGLAS RICHARD (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-12-15 Stock Option (Right to buy) $1.38 A 80000 Acquired 2027-12-15 Common Stock (80000) Direct

Footnotes

F1: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 15, 2017 grant date subject to continued service on the Company's Board of Directors through the vesting date.